Diamedica Therapeutics Inc. (DMAC)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on May 15, 2026, 6:20pm based on SEC 13F filings Last update: May 15, 2026, 6:20pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Omega Advisors Leon Cooperman	2,020,000	$13,675,400		0.45%
2.	Millennium Management Israel Englander	935,592	$6,333,958	+22%	0%
3.	Citadel Investment Group Ken Griffin	145,724	$986,551	+32%	0%
4.	Kalehua Capital Management Tai-Li Chang	62,488	$423,044	-35%	0.29%
5.	ExodusPoint Capital Michael Gelband	60,011	$406,274		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Stahlberg Large Shareholder	$8.57	73,099	$626,816.62	8,825,742	2025-11-25	Filing
Stahlberg Large Shareholder	$7.89	40,253	$317,720.95	8,752,643	2025-11-24	Filing
Stahlberg Large Shareholder	$7.41	208,872	$1,547,574.42	8,712,390	2025-11-21	Filing
Stahlberg Large Shareholder	$7.41	128,426	$951,212.85	8,503,518	2025-11-20	Filing
Stahlberg Large Shareholder	$7.21	240,352	$1,732,361.08	8,375,092	2025-11-19	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Von Large Shareholder	$1.24	2,855,847	$3,526,971.05	0	2022-12-02	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	1,856,187	$12,566,385	0%
2.	Paragon Associates & Paragon Associates Ii Joint Venture	875,000	$5,923,750	8.05%
3.	Geode Capital Management, Llc	780,516	$5,285,410	0%
4.	State Street Corp	644,211	$4,361,308	0%
5.	First Manhattan Co	455,000	$3,080,350	0.01%